Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Novartis gets FDA nod for rare blood disorder drug

Promacta will provide a treatment option for children over 6 years old

- PMLiVE

GW Pharma appoints Julian Gangolli as North American president

Appointment coincides with GW Pharma’s US launch

- PMLiVE

Immodulon Therapeutics appointments two new board of directors

Anthony Bolton and Sir Simon Robertson join the biopharma firm

- PMLiVE

Novo Nordisk becomes diabetes drug sales leader

Supplants former frontrunner Sanofi - but both firms set for a tough 2015

- PMLiVE

AZ’s phase III gout data frustrates firm

Lesinurad discrepancies highlighted in clinical trials

- PMLiVE

FDA approves brain implant for Parkinson’s disease

The Brio Neurostimulation System also found to improve essential tremor

- PMLiVE

Former Sanofi UK MD to head Teva UK

Steve Oldfield has been named as the firm’s new general manager

Teva Pharma logo

Teva set for FDA verdict on reslizumab early next year

Ruling for severe asthma therapy Cinquil expected by March 2016

ASCO 2015: What you missed in Chicago

Blue Latitude sent two of our consultants to Chicago to attend ASCO 2015, a key annual meeting for oncology specialists that brings over 30,000 delegates together to talk about innovations...

Blue Latitude Health

- PMLiVE

Astellas’ Xtandi cancer drug rejected by NICE

England’s HTA questions the treatment’s efficacy and cost

- PMLiVE

Rock Unlimited appoints Ben Fisher as its director

Joins Terry Bradley and Clare Peck on the Rock Unlimited board

- PMLiVE

MERS-CoV deaths rise with few drugs in pipeline

The death toll in South Korea reaches 16 as WHO hosts emergency meeting

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links